Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000698829 | SCV000827518 | pathogenic | Hereditary pancreatitis | 2018-05-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg29*) in the CTRC gene. It is expected to result in an absent or disrupted protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with CTRC-related disease. Loss-of-function variants in CTRC are known to be pathogenic (PMID: 22942235). For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV000698829 | SCV002681344 | pathogenic | Hereditary pancreatitis | 2024-05-31 | criteria provided, single submitter | clinical testing | The p.R29* pathogenic mutation (also known as c.85C>T), located in coding exon 2 of the CTRC gene, results from a C to T substitution at nucleotide position 85. This changes the amino acid from an arginine to a stop codon within coding exon 2. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Revvity Omics, |
RCV003489821 | SCV004238132 | likely pathogenic | not provided | 2021-03-12 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000698829 | SCV004807000 | likely pathogenic | Hereditary pancreatitis | 2024-03-26 | criteria provided, single submitter | clinical testing |